logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Dishman raises ECB limit to CHF 200m in FY26

DCAL

Dishman Carbogen Amcis Ltd

DCAL

Ask AI

Ask AI

What the board approved on May 19, 2026

Dishman Carbogen Amcis Limited said its Board of Directors, in a meeting held on May 19, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The same meeting also cleared a set of financing and governance decisions that are likely to matter to lenders and shareholders. These included the re-appointment of statutory auditors and an upward revision in the company’s external commercial borrowing plan.

The company disclosed that its auditors, M/s T R Chadha & Co. LLP, Chartered Accountants, issued an unmodified opinion on the audited results. While the detailed financials were not included in the update, the unmodified opinion indicates there were no qualifications flagged in the audit report.

ECB ceiling raised to CHF 200 million from CHF 135 million

A key decision from the meeting was the board’s approval to raise external commercial borrowings (ECB) up to CHF 200 million from Aamanya AG, a promoter group company. This revises the earlier proposed ECB limit of CHF 135 million.

The company said the proposed ECB will be used to refinance existing debt and also support working capital, capital expenditure requirements, and other permitted end-uses. The move positions the company to potentially replace a portion of rupee borrowings with a long-tenor foreign-currency facility, subject to regulatory and shareholder processes.

Loan terms: unsecured, 10-year tenor, SARON-linked pricing

Dishman Carbogen Amcis described the proposed ECB as an unsecured loan with a tenor of 10 years. The interest rate is SARON plus 400 basis points, and the company indicated the current all-in rate is about 4% per annum.

SARON, the Swiss Average Rate Overnight, is a benchmark for Swiss franc interest rates. By choosing a floating-rate structure linked to SARON, the effective cost will vary with benchmark movements, but the company has disclosed the prevailing rate at the time of the announcement.

Borrowing limits proposed to rise to ₹4,000 crore

Following the ECB decision, the board also approved an increase in overall borrowing limits under Section 180(1)(c) of the Companies Act, 2013. The limit is proposed to be raised from ₹1,700 crore to ₹4,000 crore.

The company clarified that this increase will require shareholder approval. It plans to seek consent for both the ECB and the revised borrowing limits through an Extra-Ordinary General Meeting (EGM). The EGM date will be communicated later.

Why refinancing is central to the funding plan

The stated purpose of the CHF 200 million ECB is refinancing existing rupee debt, alongside funding working capital and capex needs. The company’s updates in recent quarters have repeatedly referenced debt and refinancing actions, including domestic debt instruments.

Separately, Dishman Carbogen Amcis has reported long-term debt of ₹1,149.19 crore as of March 2025, up from ₹245.61 crore as of March 2024, based on figures included in the provided information set. Against that backdrop, the proposed ECB and the higher overall borrowing ceiling indicate the company is keeping multiple funding options open while reshaping its debt profile.

Snapshot: key facts disclosed by the company

ItemDetail
Board meeting dateMay 19, 2026
Results approvedAudited standalone and consolidated results for Q4 and year ended March 31, 2026
AuditorT R Chadha & Co. LLP
Audit opinionUnmodified
ECB lenderAamanya AG
ECB approved limitCHF 200 million (approx. ₹2,452 crore)
Earlier proposed ECB limitCHF 135 million
ECB pricingSARON + 400 bps (currently ~4% p.a.)
ECB tenor10 years
SecurityUnsecured
Proposed borrowing limit (Section 180(1)(c))Increase from ₹1,700 crore to ₹4,000 crore
Shareholder processEGM to seek approvals; date to be communicated

Operations update: Shanghai unit clears unannounced NMPA inspection

In a separate operational update, Dishman Carbogen Amcis said its wholly-owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., cleared an unannounced Good Manufacturing Practice (GMP) inspection by China’s National Medical Products Administration (NMPA). The inspection was conducted at the Shanghai facility on April 14, 2026, and the company’s disclosure said it concluded with no observations identified.

The inspection scope covered API manufacturing operations, quality control laboratories, documentation practices, and quality management systems. The company added that recommendations were provided for continuous improvement, and no issues requiring formal explanation were identified.

How this fits with recent domestic debt actions

The company has also used domestic debt markets. It completed the allotment of 5,000 non-convertible debentures (NCDs) worth ₹50 crore on January 20, 2026, with a three-year maturity ending January 20, 2029, and early redemption options. Earlier disclosures also referenced board approvals around NCD fundraising, including a ₹50 crore issuance plan carrying a 10% annual coupon with quarterly payments.

These actions, combined with a proposed CHF-denominated ECB, suggest a diversified approach to liabilities: domestic debentures for shorter or medium tenors and an overseas borrowing line aimed at refinancing and longer-duration funding.

Market context and stock snapshot included in the data

The provided information set also referenced that Dishman Carbogen Amcis had a market capitalisation of ₹3,624 crore and traded at ₹208.15, down 35.19% from its 52-week high of ₹321.15 and near its 52-week low of ₹180.00. While the company’s announcement did not link the board actions to stock performance, the details provide a context of how investors have been pricing the company during the period.

Why the approvals matter

The immediate significance of the announcement is procedural and financial. Procedurally, the ECB and the higher borrowing limit need shareholder approval through an EGM, which becomes the next milestone. Financially, the company has disclosed a clear intent to refinance rupee debt using a long-tenor, unsecured ECB priced off SARON.

The approvals also sit alongside operational compliance signals such as the Shanghai facility’s GMP inspection outcome. For a CDMO and API-focused group, regulatory inspection outcomes can influence customer confidence and continuity of operations.

Conclusion

Dishman Carbogen Amcis has raised its proposed ECB ceiling to CHF 200 million and moved to lift its overall borrowing limit to ₹4,000 crore, subject to shareholder approval at an upcoming EGM. The company has said the ECB proceeds will be used primarily for refinancing, alongside working capital and capex needs. The next update to watch is the EGM date and the final shareholder resolutions that enable the company to proceed with the revised borrowing plan.

Frequently Asked Questions

The board approved raising ECB up to CHF 200 million from Aamanya AG, a promoter group company, revising the earlier proposed limit of CHF 135 million.
The loan is unsecured, has a 10-year tenor, and carries interest at SARON + 400 bps, which the company indicated is currently around 4% per annum.
The company said the funds will be used to refinance existing rupee debt and also for working capital, capital expenditure requirements, and other permitted purposes.
The board approved increasing borrowing limits under Section 180(1)(c) from ₹1,700 crore to ₹4,000 crore, subject to shareholder approval.
The company said the April 14, 2026 inspection by China’s NMPA concluded with no observations, and no issues requiring formal explanation were identified.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker